Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard I Hurtig

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Acta Neuropathologica|March 17, 2010
Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairmentWilliam T Hu, Alice Chen-Plotkin, Steven E Arnold, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2009
Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's diseaseDaniel Weintraub, Staci Hoops, Judy A Shea, et al.
Annals of Neurology|March 1, 2013
Plasma apolipoprotein A1 as a biomarker for Parkinson diseaseJudy K Qiang, Yvette C Wong, Andrew Siderowf, et al.
Annals of Neurology|May 24, 2006
Frontotemporal dementia: clinicopathological correlationsMark S Forman, Jennifer Farmer, Julene K Johnson, et al.
Neurology|February 23, 2018
CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disordersDavid J Irwin, Sharon X Xie, David Coughlin, et al.
Annals of Neurology|April 27, 2011
Plasma epidermal growth factor levels predict cognitive decline in Parkinson diseaseAlice S Chen-Plotkin, William T Hu, Andrew Siderowf, et al.
Annals of Neurology|December 15, 2018
Cognitive and Pathological Influences of Tau Pathology in Lewy Body DisordersDavid Coughlin, Sharon X Xie, Mendy Liang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 6, 2016
Arguing against the proposed definition changes of PDBradley F Boeve, Dennis W Dickson, John E Duda, et al.
The Lancet. Neurology|December 17, 2016
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysisDavid J Irwin, Murray Grossman, Daniel Weintraub, et al.
Neurology|August 3, 2012
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer diseaseWilliam T Hu, David M Holtzman, Anne M Fagan, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Acta Neuropathologica|March 17, 2010
Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairmentWilliam T Hu, Alice Chen-Plotkin, Steven E Arnold, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2009
Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's diseaseDaniel Weintraub, Staci Hoops, Judy A Shea, et al.
Annals of Neurology|March 1, 2013
Plasma apolipoprotein A1 as a biomarker for Parkinson diseaseJudy K Qiang, Yvette C Wong, Andrew Siderowf, et al.
Annals of Neurology|May 24, 2006
Frontotemporal dementia: clinicopathological correlationsMark S Forman, Jennifer Farmer, Julene K Johnson, et al.
Neurology|February 23, 2018
CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disordersDavid J Irwin, Sharon X Xie, David Coughlin, et al.
Annals of Neurology|April 27, 2011
Plasma epidermal growth factor levels predict cognitive decline in Parkinson diseaseAlice S Chen-Plotkin, William T Hu, Andrew Siderowf, et al.
Annals of Neurology|December 15, 2018
Cognitive and Pathological Influences of Tau Pathology in Lewy Body DisordersDavid Coughlin, Sharon X Xie, Mendy Liang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 6, 2016
Arguing against the proposed definition changes of PDBradley F Boeve, Dennis W Dickson, John E Duda, et al.
The Lancet. Neurology|December 17, 2016
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysisDavid J Irwin, Murray Grossman, Daniel Weintraub, et al.
Neurology|August 3, 2012
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer diseaseWilliam T Hu, David M Holtzman, Anne M Fagan, et al.
Pageof 6